about us | leadership | board of directors | scientific advisors
Alpine Immune Sciences was founded in 2015 by experts in the field of recombinant protein based immunotherapies and a team responsible for the FDA’s approval of the world’s first cancer immunotherapy. We were created to capitalize on our unique understanding of immunology, modifying the complexities of the immune synapse for the benefit of patients living with cancer and autoimmune/inflammatory disorders.